ArticleStatistics in medicine2026
A Group Structure Guided Ultra-High Dimensional Feature Screening for Survival Outcome.
Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
With the rapid advancement of high-throughput technologies, feature screening methods have attracted increasing attention for analyzing ultra-high-dimensional data. Motivated by the widespread availability of meaningful grouping structures in biomedical applications, such as brain imaging and gene expression studies, we propose a novel group-structure-guided (GSG) feature screening method for survival outcomes. The proposed approach incorporates prior grouping information among predictors and accommodates both disjoint and overlapping group structures. Furthermore, a combined GSG (C-GSG) extension is developed to integrate multiple grouping schemes. We establish the sure screening properties of the proposed procedures and demonstrate through extensive simulation studies that incorporating informative group structures can improve screening performance, particularly under challenging censoring scenarios. The proposed method is further applied to a TCGA breast cancer dataset, where pathway information is utilized to identify genes associated with patient survival outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.